The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Risks and Benefits

Risks and Benefits

September 1, 2009 • By David S. Pisetsky, MD, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
David S. Pisetsky, MD, PhD

Right after I finished my PhD degree (studying, among other things, the mode of action of the antibiotic nalidixic acid), I started my medical clerkship on the wards of a venerable New York City hospital. This was the kind of hospital that in a movie would be called Fort Apache, and the physical exam of the patient would start with a search for guns and knives. There, with my very first patient, I learned important lessons about drug safety.

You Might Also Like
  • Medical Marijuana’s Potential Benefits, Risks
  • Long-Term Benefits, Risks of Biologic Disease-Modifying Anti-Rheumatic Drugs in Patients with RA
  • FDA Update: Possible Heart Risks with Clarithromycin; Apadaz Receives FDA Approval
Explore This Issue
September 2009
Also By This Author
  • On the Road in Rajasthan: Vehicular-Caused Bone, Joint Damage in India

The patient was an elderly woman in her seventies who, frail and frightened, was breathing about 40 times a minute. Her chest was full of bubbly noises that were loud and sinister, and her EKG showed ST segment elevations that hit the top of the tracing. The diagnosis was easy—pulmonary edema in the setting of a myocardial infarction—and, with the magic of MOSTAMP (morphine, oxygen, sitting, tourniquets, aminophylline), her breathing calmed and she looked much more comfortable.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Just as we were about to move the woman from the treatment room to a bed on the ward, the resident came in and, after detecting a few bibasilar rales, told the intern to give the patient some intravenous digoxin. “Dig” was then a popular treatment for heart failure, although its use in the setting of an ischemic cardiac event was uncertain at best. The resident and intern argued, their voices rising and their faces turning red. Despite reference to high-class studies (evidence-based medicine was alive and well even in 1972), the intern capitulated and, exasperated, pushed a bolus of dig through the woman’s intravenous line.

The sequence of event remains vivid in my mind today. Within a few minutes of the dig administration, the heart monitor began to beep wildly and the screen exploded with a profusion of mean-looking extra beats, which were obviously premature ventricular contractions (PVCs). The PVCs then burst more frequently—machine-gun blasts of four, five, or six in a run—and degenerated into sustained ventricular tachycardia. The old lady looked as if she were in shock, and her eyes rolled ominously into her head.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Alarmed by impending disaster, we then gave the woman a bolus of lidocaine, which can settle down the sodium channels in her heart. We were happy when the monitor showed sinus rhythm. Our relief was short-lived, however, when, to our chagrin and dismay, the old lady had a grand mal seizure, and her small body flapped uncontrollably.

Pages: 1 2 3 | Single Page

Filed Under: Opinion, Rheuminations, Safety Tagged With: Patients, Quality, seizure, TreatmentIssue: September 2009

You Might Also Like:
  • Medical Marijuana’s Potential Benefits, Risks
  • Long-Term Benefits, Risks of Biologic Disease-Modifying Anti-Rheumatic Drugs in Patients with RA
  • FDA Update: Possible Heart Risks with Clarithromycin; Apadaz Receives FDA Approval
  • FDA Updates Boxed Warning of Benzodiazepines, Adding Risks for Abuse & Addiction

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)